Featured Faculty
David H. Rubin, MD
Executive Director Massachusetts General Hospital Psychiatry AcademyDirector of Child and Adolescent Psychiatry Residency Training Massachusetts General Hospital and McLean Hospital
Joseph Biederman, MD
Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD Director, The Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum DisordersDr. Biederman is Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD at the Massachusetts General Hospital, Director of the Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorders at the Massachusetts General Hospital, and Professor of Psychiatry at the Harvard Medical School.
Maurizio Fava, MD
Psychiatrist-In-Chief, Department of Psychiatry Director, Division of Clinical Research, Mass General Research Institute; Executive Director, Clinical Trials Network & Institute Associate Dean for Clinical & Translational Research, Slater Family Professor of Psychiatry, Harvard Medical SchoolDr. Fava obtained his MD from the University of Padova School of Medicine where he completed residency training in endocrinology. He completed residency training in psychiatry at Mass General.
Dr. Fava obtained his MD from the University of Padova School of Medicine where he completed residency training in endocrinology. He completed residency training in psychiatry at Mass General. He founded and was Director of the hospital’s Depression Clinical and Research Program (DCRP) from 1990 to 2014. In 2007, he founded and is now Executive Director of the Mass General Psychiatry Clinical Trials Network and Institute (CTNI), the first academic CRO specialized in planning and coordination of multi-center clinical trials in psychiatry.
Under Dr. Fava’s direction, the DCRP became one of the most highly regarded depression programs in the country, a model for academic programs that link, in a bi-directional fashion, clinical and research work. Dr. Fava has been successful in obtaining funding as principal or co-principal investigator from both the National Institutes of Health and other sources for a total of more than $95,000,000. His prominence in the field is reflected in his role as the co-principal investigator of STAR*D, the largest research study ever conducted in the area of depression, and of the RAPID Network, the NIMH-funded series of studies of novel, rapidly-acting antidepressant therapies.
Dr. Fava is a world leader in the field of depression. He has authored or co-authored more than 800 original articles published in medical journals with international circulation, edited eight books, and published more than 50 chapters and over 600 abstracts.
Maurizio Fava, MD
Psychiatrist-In-Chief, Department of Psychiatry Director, Division of Clinical Research, Mass General Research Institute; Executive Director, Clinical Trials Network & Institute Associate Dean for Clinical & Translational Research, Slater Family Professor of Psychiatry, Harvard Medical SchoolDr. Fava obtained his MD from the University of Padova School of Medicine where he completed residency training in endocrinology. He completed residency training in psychiatry at Mass General.
Dr. Fava obtained his MD from the University of Padova School of Medicine where he completed residency training in endocrinology. He completed residency training in psychiatry at Mass General. He founded and was Director of the hospital’s Depression Clinical and Research Program (DCRP) from 1990 to 2014. In 2007, he founded and is now Executive Director of the Mass General Psychiatry Clinical Trials Network and Institute (CTNI), the first academic CRO specialized in planning and coordination of multi-center clinical trials in psychiatry.
Under Dr. Fava’s direction, the DCRP became one of the most highly regarded depression programs in the country, a model for academic programs that link, in a bi-directional fashion, clinical and research work. Dr. Fava has been successful in obtaining funding as principal or co-principal investigator from both the National Institutes of Health and other sources for a total of more than $95,000,000. His prominence in the field is reflected in his role as the co-principal investigator of STAR*D, the largest research study ever conducted in the area of depression, and of the RAPID Network, the NIMH-funded series of studies of novel, rapidly-acting antidepressant therapies.
Dr. Fava is a world leader in the field of depression. He has authored or co-authored more than 800 original articles published in medical journals with international circulation, edited eight books, and published more than 50 chapters and over 600 abstracts.
Joseph Biederman, MD
Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD Director, The Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum DisordersDr. Biederman is Chief of the Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD at the Massachusetts General Hospital, Director of the Alan and Lorraine Bressler Clinical and Research Program for Autism Spectrum Disorders at the Massachusetts General Hospital, and Professor of Psychiatry at the Harvard Medical School.
Tim Wilens, MD
Chief, Division of Child and Adolescent Psychiatry Co-Director, Center for Addiction Medicine Director, Substance Abuse Services in Pediatric Psychopharmacology; Professor of Psychiatry, Harvard Medical SchoolDr. Timothy Wilens is chief of the Division of Child and Adolescent Psychiatry and is co-director of the Center for Addiction Medicine at Massachusetts General Hospital.
David H. Rubin, MD
Executive Director Massachusetts General Hospital Psychiatry AcademyDirector of Child and Adolescent Psychiatry Residency Training Massachusetts General Hospital and McLean Hospital
Dr. Rubin is the Director of the Child and Adolescent Psychiatry Residency Training Program of Massachusetts General Hospital and McLean Hospital and the Director of Postgraduate Education for Massachusetts General Hospital. He also serves as the Executive Director for the MGH Psychiatry Academy.
Dr. Rubin completed an internship in Internal Medicine and a residency in general psychiatry at Dartmouth-Hitchcock Medical Center prior to his fellowship in child and adolescent psychiatry at MGH and McLean hospital. Following fellowship, Dr. Rubin joined the faculty of New York-Presbyterian/ Weill Cornell Medical Center where he served as Director of Inpatient Services, Director of the Day Hospital, Site Training Director and ultimately as Service Chief before returning to MGH and McLean to assume the directorship of the program that trained him.
Dr. Rubin’s biological research focuses on the genotypic and phenotypic characterization of social withdrawal in children and adolescents, with a particular emphasis on how this relates to severe depression and anxiety in youth. Dr. Rubin also conducts medical education research in innovation, design, implementation, dissemination and outcome measurement.
Dr. Rubin’s clinical career has largely concentrated on severe manifestations of psychopathology, particularly in the realm of depression, anxiety and neuropsychiatric illness. He has extensive experience in inpatient, residential, day hospital and emergency room care and administration and regularly performs institutional level consults to improve clinical standards and outcomes for those environments.
Dr. Rubin is an invited lecturer nationally on topics related to withdrawn behavior in youth, the treatment of pediatric depression and medical education across the medical student to postgraduate continuum. He also frequently consults to the popular media, and was featured in Horizon Films’ documentary The Passage of Time.
John Kelly, PhD
Staff Psychologist Professor of Psychiatry in Addiction Medicine at Harvard Medical SchoolDr. Kelly is the Elizabeth R. Spallin Professor of Psychiatry in the Field of Addiction Medicine at Harvard Medical School – the first endowed professor in addiction medicine at Harvard.
Laura G. Kehoe, MD, MPH
Medical Director, Bridge Clinic, Substance Use Disorder Initiative Massachusetts General Hospital Assistant Professor of Medicine Harvard Medical SchoolDr. Kehoe is the medical director of the Massachusetts General Hospital Substance Use Disorder Bridge Clinic, an immediate access, low barrier transitional clinic, which is a component of MGH’s Substance Use Disorder Initiative.
Jerry Rosenbaum, MD
Psychiatrist-in-Chief emeritus Director Center for Anxiety and Traumatic Stress DisordersPsychiatrist-in-Chief, Emeritus Director, Center for the Neuroscience of Psychedelics Massachusetts General Hospital Stanley Cobb Professor of Psychiatry Harvard Medical School Dr. Rosenbaum is recognized as one of the world's foremost authorities on mood and anxiety disorders, with a special emphasis on pharmacotherapy of those conditions.
Sabine Wilhelm, PhD
Chief of Psychology, Massachusetts General Hospital (MGH) Director, OCD and Related Disorders Program, MGH Professor, Harvard Medical SchoolDr. Sabine Wilhelm is the Chief of Psychology and the Director of the Obsessive-Compulsive and Related Disorders Program at Massachusetts General Hospital. She is a Professor of Psychology (Psychiatry) at Harvard Medical School.
Aude I. Henin, PhD
Co-Director, Child Cognitive-Behavioral Therapy Program, MGHDr. Aude Henin is co-Founder and co-Director of the Child Cognitive Behavior Therapy Program in the Department of Psychiatry at Massachusetts General Hospital, and an Assistant Professor of Psychology at Harvard Medical School.
Susan Sprich, PhD
Director, Postgraduate Psychology Education, MGH Psychiatry Academy Director, Cognitive Behavioral Therapy Program, MGH Assistant Professor of Psychology, Harvard Medical SchoolDr. Sprich is the Director of the Cognitive-Behavioral Therapy Program at Massachusetts General Hospital (MGH).
Andrew Nierenberg, MD
Thomas P. Hackett, MD, Endowed Chair in Psychiatry Director, Dauten Family Center for Bipolar Treatment Innovation Associate Director, Depression Clinical and Research Program Director, Training and Education, MGH Research Institute Professor of Psychiatry, Harvard Medical SchoolAndrew A. Nierenberg, MD holds the Thomas P. Hackett, MD, Endowed Chair in Psychiatry at Massachusetts General Hospital (MGH) and is the Director of the Dauten Family Center for Bipolar Treatment Innovation, Associate Director of the Depression Clinical and Research Program, and Director of Center for Clinical Research Education, Division of Clinical Research, MGH Research Institute. Dr. Nierenberg’s academic appointment is Professor of Psychiatry at Harvard Medical School.
Oliver Freudenreich, MD
Co-Director, the MGH Psychosis Clinical and Research Program; Director, MGH Fellowship in Public and Community PsychiatryDr. Freudenreich works as an attending psychiatrist and resident supervisor in the the MGH Psychosis Clinical and Research Program.
Marlene P. Freeman, MD
Associate Director, Perinatal and Reproductive Psychiatry Clinical Research Program Massachusetts General Hospital, Professor of Psychiatry Harvard Medical SchoolDr. Marlene Freeman is the Associate Medical Director, Clinical Trials Network & Institute; Director of Clinical Services, Perinatal and Reproductive Psychiatry Program, Massachusetts General Hospital; Professor of Psychiatry, Harvard Medical School. Dr. Freeman completed medical school at Northwestern University Medical School.
Lee S. Cohen, MD
Director, Ammon-Pinizzotto Center for Women’s Mental Health Perinatal and Reproductive Psychiatry Clinical Research Program Massachusetts General Hospital, Edmund and Carroll Carpenter Professor of Psychiatry Harvard Medical SchoolDr. Lee Cohen is Director of the Center for Women’s Mental Health at Massachusetts General Hospital (MGH) and is the first incumbent of the Edmund and Carroll Carpenter Chair in Psychiatry in Women’s Mental Health at Harvard Medical School.